Literature DB >> 25264688

Sanofi Pasteur shows efficacy of its dengue vaccine in phase 3.

Eva M Riedmann1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25264688      PMCID： PMC5396245          DOI： 10.4161/hv.32075

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN： 2164-5515            Impact factor:   3.452


× No keyword cloud information.
  2 in total

1.  Rapid increase in pertactin-deficient Bordetella pertussis isolates, Australia.

Authors:  Connie Lam; Sophie Octavia; Lawrence Ricafort; Vitali Sintchenko; Gwendolyn L Gilbert; Nicholas Wood; Peter McIntyre; Helen Marshall; Nicole Guiso; Anthony D Keil; Andrew Lawrence; Jenny Robson; Geoff Hogg; Ruiting Lan
Journal:  Emerg Infect Dis       Date:  2014-04       Impact factor: 6.883

2.  Purified coronavirus spike protein nanoparticles induce coronavirus neutralizing antibodies in mice.

Authors:  Christopher M Coleman; Ye V Liu; Gale E Smith; Matthew B Frieman; Haiyan Mu; Justin K Taylor; Michael Massare; David C Flyer
Journal:  Vaccine       Date:  2014-04-13       Impact factor: 3.641
  2 in total
  1 in total

1.  Pediatric infectious diseases: getting research evidence into practice and generation of new evidence.

Authors:  Hans Van Rostenberghe
Journal:  Front Pediatr       Date:  2014-12-08       Impact factor: 3.418
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.